Moderna (Germany) Performance
| 0QF Stock | EUR 44.24 1.45 3.39% |
Moderna holds a performance score of 18 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -1.2, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Moderna are expected to decrease by larger amounts. On the other hand, during market turmoil, Moderna is expected to outperform it. Use Moderna downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to analyze future returns on Moderna.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Moderna are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Moderna reported solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Down 80, Should You Buy the Dip on Moderna - The Motley Fool | 12/19/2025 |
2 | Moderna V940Keytruda Data And Vaccine Revenues Drive A High-Risk Recovery Story - Seeking Alpha | 01/13/2026 |
3 | Moderna Joins Elite Club Of Stocks With RS Ratings Over 90 - Investors Business Daily | 01/20/2026 |
4 | Why Modernas Stock Is Dropping Despite Cancer Hopes - TipRanks | 01/23/2026 |
5 | Moderna Shifts Vaccine Funding Approach And Expands mRNA Oncology Ambitions - simplywall.st | 01/29/2026 |
6 | Moderna Stock Falls Amid Market Uptick What Investors Need to Know - Nasdaq | 02/02/2026 |
7 | Defiance adds single stock ETFs tied to Zeta Global, Moderna - Structured Retail Products | 02/05/2026 |
8 | Moderna shares slide 7 percent after FDA refuses to review flu vaccine - Investing.com | 02/10/2026 |
9 | Earnings live Moderna stock pops on revenue growth, Rivian surges, Applied Materials jumps - Yahoo Finance | 02/13/2026 |
10 | RBC raises Moderna stock price target to 30 on pipeline progress - Investing.com | 02/17/2026 |
11 | Piper Sandler raises Moderna stock price target on vaccine pipeline - Investing.com | 02/23/2026 |
| Begin Period Cash Flow | 2.9 B | |
| Free Cash Flow | -4.1 B |
Moderna |
Moderna Relative Risk vs. Return Landscape
If you would invest 2,181 in Moderna on November 28, 2025 and sell it today you would earn a total of 2,243 from holding Moderna or generate 102.84% return on investment over 90 days. Moderna is currently producing 1.3369% returns and takes up 5.6258% volatility of returns over 90 trading days. Put another way, 50% of traded stocks are less volatile than Moderna, and 74% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Moderna Target Price Odds to finish over Current Price
The tendency of Moderna Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 44.24 | 90 days | 44.24 | under 4 |
Based on a normal probability distribution, the odds of Moderna to move above the current price in 90 days from now is under 4 (This Moderna probability density function shows the probability of Moderna Stock to fall within a particular range of prices over 90 days) .
Moderna Price Density |
| Price |
Predictive Modules for Moderna
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Moderna. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Moderna Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Moderna is not an exception. The market had few large corrections towards the Moderna's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Moderna, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Moderna within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.36 | |
β | Beta against Dow Jones | -1.2 | |
σ | Overall volatility | 7.29 | |
Ir | Information ratio | 0.21 |
Moderna Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Moderna for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Moderna can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Moderna is way too risky over 90 days horizon | |
| Moderna appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 3.2 B. Net Loss for the year was (3.56 B) with loss before overhead, payroll, taxes, and interest of (2.06 B). | |
| Moderna has accumulated about 7.99 B in cash with (3 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.8. | |
| Over 77.0% of the company shares are owned by institutions such as pension funds | |
| Latest headline from news.google.com: Piper Sandler raises Moderna stock price target on vaccine pipeline - Investing.com |
Moderna Fundamentals Growth
Moderna Stock prices reflect investors' perceptions of the future prospects and financial health of Moderna, and Moderna fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Moderna Stock performance.
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (1.45) % | ||||
| Operating Margin | (1.26) % | ||||
| Current Valuation | 5.67 B | ||||
| Shares Outstanding | 390.73 M | ||||
| Price To Earning | 237.44 X | ||||
| Price To Book | 1.17 X | ||||
| Price To Sales | 8.75 X | ||||
| Revenue | 3.2 B | ||||
| Gross Profit | (2.06 B) | ||||
| EBITDA | (2.86 B) | ||||
| Net Income | (3.56 B) | ||||
| Cash And Equivalents | 7.99 B | ||||
| Cash Per Share | 19.80 X | ||||
| Total Debt | 3.24 B | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 1.24 X | ||||
| Book Value Per Share | 18.65 X | ||||
| Cash Flow From Operations | (3 B) | ||||
| Earnings Per Share | (6.17) X | ||||
| Market Capitalization | 17 B | ||||
| Total Asset | 14.14 B | ||||
| Retained Earnings | 10.04 B | ||||
| Working Capital | 5.89 B | ||||
About Moderna Performance
By analyzing Moderna's fundamental ratios, stakeholders can gain valuable insights into Moderna's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Moderna has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Moderna has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 64.34 | 61.12 | |
| Return On Tangible Assets | (0.23) | (0.22) | |
| Return On Capital Employed | (0.30) | (0.28) | |
| Return On Assets | (0.23) | (0.22) | |
| Return On Equity | (0.33) | (0.31) |
Things to note about Moderna performance evaluation
Checking the ongoing alerts about Moderna for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Moderna help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Moderna is way too risky over 90 days horizon | |
| Moderna appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 3.2 B. Net Loss for the year was (3.56 B) with loss before overhead, payroll, taxes, and interest of (2.06 B). | |
| Moderna has accumulated about 7.99 B in cash with (3 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.8. | |
| Over 77.0% of the company shares are owned by institutions such as pension funds | |
| Latest headline from news.google.com: Piper Sandler raises Moderna stock price target on vaccine pipeline - Investing.com |
- Analyzing Moderna's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Moderna's stock is overvalued or undervalued compared to its peers.
- Examining Moderna's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Moderna's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Moderna's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Moderna's stock. These opinions can provide insight into Moderna's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Moderna Stock analysis
When running Moderna's price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |